中国肝豆状核变性诊治指南2021更新要点解读  

Interpretation of updated key points of Chinese guidelines for diagnosis and treatment of Wilson′s disease 2021

作　　者：吴志英[1] Wu Zhiying(Department of Neurology,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China)

机构地区：[1]浙江大学医学院附属第二医院神经内科,杭州310009

出　　处：《中华神经科杂志》2021年第4期303-304,共2页Chinese Journal of Neurology

基　　金：国家杰出青年科学基金(81125009)。

摘　　要：在2008年发表的《肝豆状核变性的诊断和治疗指南》基础上,结合该领域国内外相关研究进展修订的《中国肝豆状核变性诊治指南2021》,对原有肝豆状核变性的诊断标准及治疗的相关内容进行了增补和细化,内容更新至2020年8月,主要涉及肝豆状核变性的临床表现、辅助检查、诊断与鉴别诊断、治疗及预后等方面,旨在指导临床医生规范诊断和治疗我国肝豆状核变性患者。On the basis of the Guidelines for the diagnosis and treatment of Wilson′s disease 2008,the Chinese guidelines for diagnosis and treatment of Wilson′s disease 2021 has been revised by taking into account the progress of related research in this field both at home and abroad.The original diagnostic criteria and treatment have been supplemented and refined,and the content has been updated until August 2020,mainly involving clinical manifestations,auxiliary examination,diagnosis and differential diagnosis,treatment and prognosis,with the aim of guiding clinicians to standardize the diagnosis and treatment of Chinese patients with Wilson′s disease.

关 键 词：肝豆状核变性 诊断 治疗 指南 

分 类 号：R742.4[医药卫生—神经病学与精神病学]